comparemela.com

Latest Breaking News On - Renaissance technologie - Page 5 : comparemela.com

Jim Simons Trims Position in Coffee Holding Co Inc

On December 29, 2023, Renaissance Technologies, led by Jim Simons (Trades, Portfolio), reported a reduction in its holdings of Coffee Holding Co Inc (NASDAQ:JVA). Jim Simons (Trades, Portfolio), a renowned mathematician and quantitative investor, founded Renaissance Technologies in 1982.

Jim Simons Bolsters Position in PetMed Express Inc

On August 23, 2023, Renaissance Technologies, led by Jim Simons (Trades, Portfolio), executed a notable transaction in the stock market by adding 325,815 shares of PetMed Express Inc (NASDAQ:PETS) at a price of $11.33 per share. This addition has increased the firm's total holdings in PetMed Express to 1,344,284 shares, reflecting a 0.01% impact on the portfolio and marking a 6.36% ownership in the company.

Jim Simons Renaissance Technologies Adds Shares in inTest Corp

Renaissance Technologies, led by the renowned mathematician and investor Jim Simons (Trades, Portfolio), has recently expanded its investment portfolio with the addition of shares in inTest Corp (INTT). The transaction, which took place on December 29, 2023, saw the firm acquire 39,000 shares of the company, known for its test and process solutions in various high-tech markets.

Jim Simons Renaissance Technologies Adds EchoStar Corp to Its Portfolio

Renaissance Technologies, led by the renowned mathematician and investor Jim Simons (Trades, Portfolio), has recently expanded its investment portfolio with the addition of EchoStar Corp (NASDAQ:SATS). This strategic move by Simons' firm reflects a continued interest in the technology and communications sectors.

Jim Simons Bolsters Position in Innoviva Inc with Recent Acquisition

Overview of the Recent Portfolio Addition Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently expanded its investment portfolio with the addition of 4,144,447 shares in Innoviva Inc (NASDAQ:INVA). The transaction, which took place on December 29, 2023, reflects a 3.63% increase from the previous holding, marking a significant vote of confidence in the biopharmaceutical company. With a trade price of $16.04 per share, the firm has demonstrated a strategic move to capitalize on Innoviva's market potential.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.